• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX2在乳腺癌发生中的作用。

Role of RUNX2 in Breast Carcinogenesis.

作者信息

Wysokinski Daniel, Blasiak Janusz, Pawlowska Elzbieta

机构信息

Department of Molecular Genetics, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.

Department of Orthodontics, Medical University of Lodz, Pomorska 251, 92-216 Lodz, Poland.

出版信息

Int J Mol Sci. 2015 Sep 2;16(9):20969-93. doi: 10.3390/ijms160920969.

DOI:10.3390/ijms160920969
PMID:26404249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4613236/
Abstract

RUNX2 is a transcription factor playing the major role in osteogenesis, but it can be involved in DNA damage response, which is crucial for cancer transformation. RUNX2 can interact with cell cycle regulators: cyclin-dependent kinases, pRB and p21Cip1 proteins, as well as the master regulator of the cell cycle, the p53 tumor suppressor. RUNX2 is involved in many signaling pathways, including those important for estrogen signaling, which, in turn, are significant for breast carcinogenesis. RUNX2 can promote breast cancer development through Wnt and Tgfβ signaling pathways, especially in estrogen receptor (ER)-negative cases. ERα interacts directly with RUNX2 and regulates its activity. Moreover, the ERa gene has a RUNX2 binding site within its promoter. RUNX2 stimulates the expression of aromatase, an estrogen producing enzyme, increasing the level of estrogens, which in turn stimulate cell proliferation and replication errors, which can be turned into carcinogenic mutations. Exploring the role of RUNX2 in the pathogenesis of breast cancer can lead to revealing new therapeutic targets.

摘要

RUNX2是一种在成骨过程中起主要作用的转录因子,但它可参与DNA损伤反应,而这对癌症转化至关重要。RUNX2可与细胞周期调节因子相互作用:细胞周期蛋白依赖性激酶、pRB和p21Cip1蛋白,以及细胞周期的主要调节因子p53肿瘤抑制因子。RUNX2参与许多信号通路,包括对雌激素信号传导重要的那些通路,而雌激素信号传导反过来对乳腺癌发生也很重要。RUNX2可通过Wnt和Tgfβ信号通路促进乳腺癌发展,尤其是在雌激素受体(ER)阴性的病例中。ERα直接与RUNX2相互作用并调节其活性。此外,ERα基因在其启动子内有一个RUNX2结合位点。RUNX2刺激芳香化酶(一种产生雌激素的酶)的表达,增加雌激素水平,进而刺激细胞增殖和复制错误,而这些错误可转化为致癌突变。探索RUNX2在乳腺癌发病机制中的作用可有助于揭示新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/9b7458035087/ijms-16-20969-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/4de975ff4bde/ijms-16-20969-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/a19bf7ce24a1/ijms-16-20969-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/acf19d114aa3/ijms-16-20969-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/9b7458035087/ijms-16-20969-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/4de975ff4bde/ijms-16-20969-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/a19bf7ce24a1/ijms-16-20969-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/acf19d114aa3/ijms-16-20969-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b047/4613236/9b7458035087/ijms-16-20969-g004.jpg

相似文献

1
Role of RUNX2 in Breast Carcinogenesis.RUNX2在乳腺癌发生中的作用。
Int J Mol Sci. 2015 Sep 2;16(9):20969-93. doi: 10.3390/ijms160920969.
2
Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform.雌激素受体 α (ERα) 和雌激素相关受体 α (ERRα) 都是 runt 相关转录因子 2 同工型 (Runx2-I) 的转录调节因子。
Mol Cell Endocrinol. 2013 Apr 30;369(1-2):150-60. doi: 10.1016/j.mce.2013.01.024. Epub 2013 Feb 8.
3
Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.Runx2 和雌激素信号对乳腺癌转移的调控:SNAI2 的作用。
Breast Cancer Res. 2011;13(6):R127. doi: 10.1186/bcr3073. Epub 2011 Dec 9.
4
Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.雌激素受体α对Runx2活性的调节:对骨质疏松症和乳腺癌的影响。
Endocrinology. 2008 Dec;149(12):5984-95. doi: 10.1210/en.2008-0680. Epub 2008 Aug 28.
5
The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.雌激素受体α信号通路可诱导致癌性Wip1磷酸酶基因的表达。
Mol Cancer Res. 2009 May;7(5):713-23. doi: 10.1158/1541-7786.MCR-08-0247. Epub 2009 May 12.
6
Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.Runx2对印度刺猬因子的转录激活作用及乳腺癌细胞中的一条下游骨转移通路
Cancer Res. 2008 Oct 1;68(19):7795-802. doi: 10.1158/0008-5472.CAN-08-1078.
7
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.雌激素调控乳腺癌细胞周期蛋白D1及细胞周期进程所需的细胞类型特异性转录网络。
Genes Dev. 2006 Sep 15;20(18):2513-26. doi: 10.1101/gad.1446006.
8
RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.RUNX2和TAZ依赖的信号通路调节乳腺癌细胞中可溶性E-钙黏蛋白水平和肿瘤球形成。
Oncotarget. 2015 Sep 29;6(29):28132-50. doi: 10.18632/oncotarget.4654.
9
TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.TFAP2C通过雌激素信号传导的多种途径控制乳腺癌细胞中的激素反应。
Cancer Res. 2007 Sep 15;67(18):8439-43. doi: 10.1158/0008-5472.CAN-07-2293.
10
p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.通过多个转录因子反应元件对hdm2 - P2启动子进行p53非依赖性激活,导致雌激素受体α阳性乳腺癌细胞中hdm2表达升高。
Cancer Res. 2003 May 15;63(10):2616-23.

引用本文的文献

1
Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer.乳腺癌中所选信号转导和转录激活因子(STAT)抑制剂与催乳素诱导蛋白(PIP)的关联
Int J Mol Sci. 2025 Feb 7;26(4):1416. doi: 10.3390/ijms26041416.
2
Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis.实体瘤基质中X型胶原蛋白的异常表达与上皮-间质转化、免疫抑制和促转移途径、骨髓基质细胞特征以及不良生存预后相关。
BMC Cancer. 2025 Feb 12;25(1):247. doi: 10.1186/s12885-025-13641-y.
3
Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis.

本文引用的文献

1
RUNX2 RNA interference inhibits the invasion of osteosarcoma.RUNX2 RNA干扰抑制骨肉瘤的侵袭。
Oncol Lett. 2015 Jun;9(6):2455-2458. doi: 10.3892/ol.2015.3124. Epub 2015 Apr 20.
2
Recent progress in HER2 associated breast cancer.人表皮生长因子受体2相关乳腺癌的最新进展
Asian Pac J Cancer Prev. 2015;16(7):2591-600. doi: 10.7314/apjcp.2015.16.7.2591.
3
Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.内源性雌激素与乳腺癌、子宫内膜癌和卵巢癌的风险。
实体瘤基质中X型胶原蛋白的异常表达与上皮-间质转化、免疫抑制和促转移途径、骨髓基质细胞特征以及不良生存预后相关。
bioRxiv. 2024 Nov 14:2024.11.13.621984. doi: 10.1101/2024.11.13.621984.
4
RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis.RUNX家族作为骨癌中有前景的生物标志物和治疗靶点:关于其肿瘤发生背后分子机制的综述
Cancers (Basel). 2023 Jun 19;15(12):3247. doi: 10.3390/cancers15123247.
5
RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13.RUNX2通过转录激活MGAT5和MMP13促进胃癌进展。
Front Oncol. 2023 May 15;13:1133476. doi: 10.3389/fonc.2023.1133476. eCollection 2023.
6
Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.催乳素诱导蛋白(PIP)增加了乳腺癌细胞对药物诱导凋亡的敏感性。
Sci Rep. 2023 Apr 21;13(1):6574. doi: 10.1038/s41598-023-33707-w.
7
Role of RUNX2 in breast cancer development and drug resistance (Review).RUNX2在乳腺癌发展和耐药性中的作用(综述)
Oncol Lett. 2023 Mar 15;25(5):176. doi: 10.3892/ol.2023.13762. eCollection 2023 May.
8
The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context.RUNX/CBFβ 复合物在乳腺癌中的作用:一种语境的困惑。
Cells. 2023 Feb 16;12(4):641. doi: 10.3390/cells12040641.
9
SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets.SETD7表达与特定分子亚型的乳腺癌生存结果相关:对公开可用数据集的系统分析
Cancers (Basel). 2022 Dec 7;14(24):6029. doi: 10.3390/cancers14246029.
10
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies.抗雌激素治疗耐药性的分子机制及新型靶向治疗
Cancers (Basel). 2022 Oct 24;14(21):5206. doi: 10.3390/cancers14215206.
Steroids. 2015 Jul;99(Pt A):8-10. doi: 10.1016/j.steroids.2014.12.013. Epub 2014 Dec 30.
4
RUNX2: A Master Bone Growth Regulator That May Be Involved in the DNA Damage Response.RUNX2:一种可能参与DNA损伤反应的主要骨生长调节因子。
DNA Cell Biol. 2015 May;34(5):305-15. doi: 10.1089/dna.2014.2688. Epub 2015 Jan 2.
5
Estrogen receptor β: the guardian of the endometrium.雌激素受体 β:子宫内膜的守护者。
Hum Reprod Update. 2015 Mar-Apr;21(2):174-93. doi: 10.1093/humupd/dmu053. Epub 2014 Oct 10.
6
Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors.乳腺癌的候选预后标志物:聚焦细胞外蛋白酶及其抑制剂。
Breast Cancer (Dove Med Press). 2014 Jul 3;6:81-91. doi: 10.2147/BCTT.S46020. eCollection 2014.
7
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.Runx2是发育和乳腺癌中乳腺上皮细胞命运的新型调节因子。
Cancer Res. 2014 Sep 15;74(18):5277-5286. doi: 10.1158/0008-5472.CAN-14-0053. Epub 2014 Jul 23.
8
Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.雌激素信号转导的相互作用:对卵巢癌内分泌耐药性的影响
J Steroid Biochem Mol Biol. 2014 Sep;143:160-73. doi: 10.1016/j.jsbmb.2014.02.010. Epub 2014 Feb 22.
9
β-catenin enhances odontoblastic differentiation of dental pulp cells through activation of Runx2.β-连环蛋白通过激活Runx2增强牙髓细胞的成牙本质细胞分化。
PLoS One. 2014 Feb 10;9(2):e88890. doi: 10.1371/journal.pone.0088890. eCollection 2014.
10
Biological subtypes of breast cancer: current concepts and implications for recurrence patterns.乳腺癌的生物学亚型:当前概念及其对复发模式的影响
Q J Nucl Med Mol Imaging. 2013 Dec;57(4):312-21.